| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| December 22nd, 2005 | 5 | Yes |
Popular Name: Glycine Glycine
Find On: PubMed — Wikipedia — Google
CAS Numbers: 112898-03-0 , 13479-54-4 , 13682-92-3 , 14281-83-5 , 14729-84-1 , 14783-68-7 , 17169-60-7 , 200-272-2 , 207300-76-3 , 211057-02-2 , 21931-03-3 , 23791-92-6 , 35947-07-0 , 41354-48-7 , 4896-76-8 , 50610-34-9 , 56-40-6 , 6000-43-7 , 6000-44-8 , [13479-54-4] , [14783-68-7] , [20150-34-9] , [29728-27-6] , [35947-07-0] , [56-40-6] , [6000-43-7] , [6000-44-8]
(2-Aminoacetoxy)dihydroxyaluminum
14729-84-1; D08016; Ferro sanol (TN); Ferrous sulfate glycine
15743-44-9 (mono-potassium salt)
2-Aminoacetic acid hydrochloride
29728-27-6 (monoammonium salt)
35947-07-0 (calcium salt (2:1))
56-40-6; Aminoacetic acid; C00037; Gly; Glycine
56-40-6; D00011; Glycine (JP16/USP)
6000-44-8 (mono-hydrochloride salt)
63183-41-5 (hydrochloride hydrogen carbonate)
7490-95-1 (hydrochloride (2:1)
7490-95-1 (hydrochloride (2:1))
Acide aminoacetique [INN-French]
Acido aminoacetico [INN-Spanish]
Acidum aminoaceticum [INN-Latin]
Aminoacetic Acid (JAN); Glycine (FDA
AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER
B72BA06C-60E9-4A83-A24A-A2D7F465BB65
CHEBI:42964; CHEBI:5460; CHEBI:10792; CHEBI:24368; CHEBI:14344
CPD-8569; an alpha amino acid ester
GLYCINE 1.5% IN PLASTIC CONTAINER
glycine, copper(2+) salt (2:1)
Glycine, labeled with carbon-14
Glycine, sodium salt hydrate, 99%
Glycine-N,N,O-D3, 99.99% (Isotopic)
H2gly(+); NH3(+)-CH2-COOH; carboxymethanaminium; glycine cation
hydrogen [sulphato -O,O']ferrate
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | -2.55 | -0.44 | -40.12 | 3 | 3 | 0 | 68 | 75.067 | 1 | ↓ |
| Hi High (pH 8-9.5) | -2.55 | -0.82 | -42.26 | 2 | 3 | -1 | 66 | 74.059 | 1 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| UniProt Database Links | 053R_FRG3G; 068R_FRG3G; 087L_FRG3G; 123L_IIV3; 261R_IIV6; 2ABD_CHICK; 2ABD_HUMAN; 2ABD_MOUSE; 2ABD_RAT; 3BP5L_BOVIN; 3BP5L_HUMAN; 3BP5L_PONAB; 3XYN1_VIBSX; 3XYN_ALCSP; 458R_IIV6; 4FTAS_STRCT; 7DMAW_ASPFU; A16_FOWPN; A16_RABPU; A16_VACCA; A16_VACCC; A16_VA | ChEBI |
| UniProt Database Links | 053R_FRG3G; 458R_IIV6; 4FTAS_STRCT; A16_FOWPN; A16_RABPU; A16_VACCA; A16_VACCC; A16_VACCT; A16_VACCW; A16_VAR67; AACL1_BRADU; AACL2_BRADU; AACL_AGRT5; AACP1_BRADU; AACP2_BRADU; AACP_AGRT5; AAKB1_BOVIN; AAKB1_HUMAN; AAKB1_MOUSE; AAKB1_PONAB; AAKB1_RAT; AAM | ChEBI |
| Melting_Point | 175-178? | Alfa-Aesar |
| Melting_Point | 175-178° | Alfa-Aesar |
| Mp [°C] | 178 - 182 | Acros Organics |
| Mp [°C] | 182 | Acros Organics |
| Mp [°C] | 197 - 201 | Acros Organics |
| MP | 240 °C (dec.)(lit.) | Indofine |
| Melting_Point | 240? dec. | Alfa-Aesar |
| MP | 246 - 248 | Enamine Building Blocks |
| MP | 246...248 | Enamine Building Blocks |
| ALOGPS_SOLUBILITY | 5.52e+02 g/l | DrugBank-nutriceuticals |
| purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
| Purity | 95% | Fluorochem |
| Purity | 98% | Fluorochem |
| BP [°C] | >233 | Acros Organics |
| Melting_Point | ca 245? dec. | Alfa-Aesar |
| Melting_Point | ca 245° dec. | Alfa-Aesar |
| Patent Database Links | EP0806203; EP0806411; EP0811599; EP0811600; EP0870760; EP0898963; EP0922699; EP0933365; EP0971025; EP1041070; EP1043322; EP1082304; EP1088550; EP1106609; EP1110552; EP1113008; EP1123929; EP1132380; EP1151994; EP1151997; EP1157987; EP1167353; EP1219634; EP | ChEBI |
| SOLUBILITY | H2O: 100 mg/mL | Indofine |
| Notes | Ph.Eur, Pyrogen freeComponent of tris-glycine-sds running buffers forpolyacrylamide gel electrophoresis | Apollo Scientific Bioactives |
| Reactome Database Links | REACT_11108; REACT_111140; REACT_111222; REACT_11159; REACT_13449; REACT_1345; REACT_13482; REACT_13564; REACT_13677; REACT_14785; REACT_14802; REACT_14841; REACT_14843; REACT_14851; REACT_150428; REACT_15395; REACT_15471; REACT_15522; REACT_16972; REACT_ | ChEBI |
| S phrase | S24/25: Avoid contact with skin and eyes. | Acros Organics |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| GLRA1-2-E | Glycine Receptor Subunit Alpha-1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 6000 | 1.46 | Binding ≤ 10μM |
| GLRA2-2-E | Glycine Receptor Subunit Alpha-2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 6000 | 1.46 | Binding ≤ 10μM |
| GLRA3-2-E | Glycine Receptor Alpha-3 Chain (cluster #2 Of 2), Eukaryotic | Eukaryotes | 6000 | 1.46 | Binding ≤ 10μM |
| GLRA4-2-E | Glycine Receptor Alpha-4 Chain (cluster #2 Of 2), Eukaryotic | Eukaryotes | 6000 | 1.46 | Binding ≤ 10μM |
| GLRB-2-E | Glycine Receptor Beta Chain (cluster #2 Of 2), Eukaryotic | Eukaryotes | 6000 | 1.46 | Binding ≤ 10μM |
| NMDZ1-4-E | Glutamate (NMDA) Receptor Subunit Zeta 1 (cluster #4 Of 6), Eukaryotic | Eukaryotes | 6200 | 1.46 | Binding ≤ 10μM |
| Z104302-3-O | Glutamate NMDA Receptor (cluster #3 Of 7), Other | Other | 86 | 1.98 | Binding ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| NMDZ1_RAT | P35439 | Glutamate (NMDA) Receptor Subunit Zeta 1, Rat | 250 | 1.85 | Binding ≤ 1μM |
| Z104302 | Z104302 | Glutamate NMDA Receptor | 170 | 1.90 | Binding ≤ 1μM |
| NMDZ1_RAT | P35439 | Glutamate (NMDA) Receptor Subunit Zeta 1, Rat | 250 | 1.85 | Binding ≤ 10μM |
| Z104302 | Z104302 | Glutamate NMDA Receptor | 170 | 1.90 | Binding ≤ 10μM |
| GLRA1_RAT | P07727 | Glycine Receptor Alpha-1 Chain, Rat | 6000 | 1.46 | Binding ≤ 10μM |
| GLRA2_RAT | P22771 | Glycine Receptor Alpha-2 Chain, Rat | 6000 | 1.46 | Binding ≤ 10μM |
| GLRA3_RAT | P24524 | Glycine Receptor Alpha-3 Chain, Rat | 6000 | 1.46 | Binding ≤ 10μM |
| GLRA4_MOUSE | Q61603 | Glycine Receptor Alpha-4 Chain, Mouse | 6000 | 1.46 | Binding ≤ 10μM |
| GLRB_RAT | P20781 | Glycine Receptor Beta Chain, Rat | 6000 | 1.46 | Binding ≤ 10μM |
| Description | Species |
|---|---|
| CREB phosphorylation through the activation of CaMKII | |
| EPHB-mediated forward signaling | |
| Ligand-gated ion channel transport | |
| Ras activation uopn Ca2+ infux through NMDA receptor | |
| Unblocking of NMDA receptor, glutamate binding and activation |
No pre-computed analogs available. Try a structural similarity search.